FDA Approves VALIUM — Roche Laboratories Inc.

Roche Laboratories has announced a pivotal compliance update for its long-standing brand VALIUM (diazepam), confirming the continued receipt and administration of a U.S. marketing authorization for the generic oral drug. This regulatory stability bolsters the company’s position in the generic market despite the generic availability of its properties.